J. Bautista

发表

De novo mutations in the classic epileptic encephalopathies

Michael R. Johnson, I. Scheffer, H. Mefford, 2013, Nature.

De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies.

Michael R. Johnson, I. Scheffer, H. Mefford, 2014, American journal of human genetics.

Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder

Jianmin Cui, Jingyi Shi, Hans O Lüders, 2005, Nature Genetics.

The Epilepsy Phenome/Genome Project

I. Scheffer, N. Risch, R. Kuzniecky, 2013, Clinical trials.

Phenotypic analysis of 303 multiplex families with common epilepsies

I. Scheffer, H. Mefford, D. Goldstein, 2017, Brain : a journal of neurology.

Copy number variant analysis from exome data in 349 patients with epileptic encephalopathy

Michael R. Johnson, B. Coe, Niklas Krumm, 2015, Annals of neurology.

Linkage analysis of alcoholism-related electrophysiological phenotypes: genome scans with microsatellites compared to single-nucleotide polymorphisms

K. Goddard, J. Bautista, A. Parrado, 2005, BMC Genetics.

Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2004 .

Neurological disorder-associated genetic variants in individuals with psychogenic nonepileptic seizures

M. Daly, I. Najm, D. Lal, 2020, Scientific Reports.

Addressing genetic heterogeneity in complex disease: Finding seizure genes in systemic lupus erythematosus

J. Harley, J. Kelly, C. Gray-McGuire, 2008, Epilepsia.

Patient experience with patient-reported outcome measures in neurologic practice

J. Bautista, B. Lapin, I. Katzan, 2018, Neurology.

Erratum: De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies (American Journal of Human Genetics (2014) 95(4) (360–370)(S0002929714003838)(10.1016/j.ajhg.2014.08.013))

Michael R. Johnson, I. Scheffer, H. Mefford, 2017 .

Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy

B. Bourgeois, W. Marks, J. Stern, 2004, Neurology.

Efficacy and Tolerability of the New Antiepileptic Drugs , II : Treatment of Refractory Epilepsy : Report of the TTA and QSS

B. Bourgeois, W. Marks, J. Stern, 2004 .

Psychogenic nonepileptic seizure: An empathetic, practical approach

J. Bautista, B. B. S. Tilahun, 2022, Cleveland Clinic Journal of Medicine.

Ultra-rare genetic variation in common epilepsies: a case-control sequencing study

Michael R. Johnson, I. Scheffer, H. Mefford, 2017, The Lancet Neurology.

Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New‐Onset Epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2004, Epilepsia.

CME Efficacy and tolerability of the new antiepileptic drugs I : Treatment of new onset epilepsy Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2004 .

Temporal lobe neoplasm and seizures: how deep does the story go?

H. Lüders, B. Diehl, H. Morris, 2008, Epileptic disorders : international epilepsy journal with videotape.

Diverse genetic causes of polymicrogyria with epilepsy

I. Scheffer, H. Mefford, E. Eichler, 2021, Epilepsia.

Mechanism of increased open probability by a mutation of the BK channel.

G. Richerson, J. Bautista, A. Diez-Sampedro, 2006, Journal of neurophysiology.

Treatment-Refractory Epilepsy: An Evidence-Based Approach to Antiepileptic Monotherapy

C. Harden, T. Browne, A. Kanner, 2005, CNS Spectrums.

Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy

B. Bourgeois, W. Marks, J. Stern, 2004, Neurology.

Evaluating subjective cognitive impairment in the adult epilepsy clinic: Effects of depression, number of antiepileptic medications, and seizure frequency

R. Busch, J. Bautista, B. Lapin, 2018, Epilepsy & Behavior.

Focal cortical dysplasia and intractable epilepsy in adults: clinical, EEG, imaging, and surgical features

H. Lüders, W. Bingaman, J. Bautista, 2003, Epilepsy Research.

Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy

B. Bourgeois, W. Marks, J. Stern, 2004, Neurology.

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy

B. Bourgeois, J. Stern, D. Hirtz, 2018, Epilepsy currents.

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy

B. Bourgeois, J. Stern, D. Hirtz, 2018, Epilepsy currents.

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy

B. Bourgeois, J. Stern, D. Hirtz, 2018, Neurology.

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy

B. Bourgeois, J. Stern, D. Hirtz, 2018, Neurology.

Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy. Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2004 .

Quantitative analysis of phenotypic elements augments traditional electroclinical classification of common familial epilepsies

I. Scheffer, H. Mefford, D. Goldstein, 2019, Epilepsia.

Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy

B. Bourgeois, W. Marks, J. Stern, 2004, Neurology.

B. Bourgeois, W. Marks, J. Stern, 2004 .

Appendix D: Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2007 .

Focal malformations of cortical development

G. Cascino, S. Spencer, F. Andermann, 2004, Neurology.

De Novo Mutations in Synaptic Transmission Genes Including DNM1 Cause Epileptic Encephalopathies.

H. Mefford, P. May, R. Krause, 2017, American journal of human genetics.

De novo mutations in the classic epileptic encephalopathies

Michael R. Johnson, I. Scheffer, H. Mefford, 2013, Nature.

Evaluating subjective cognitive impairment in the adult epilepsy clinic: Effects of depression, number of antiepileptic medications, and seizure frequency

R. Busch, J. Bautista, B. Lapin, 2018, Epilepsy & Behavior.

Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society

B. Bourgeois, W. Marks, J. Stern, 2004, Epilepsia.

Bridging a clinical gap in psychogenic nonepileptic seizures: Mental health provider preferences of biopsychosocial assessment approaches

J. Bautista, P. Ford, G. Tesar, 2016, Epilepsy & Behavior.

Diagnostic assessment and case formulation in psychogenic nonepileptic seizures: A pilot comparison of approaches

J. Bautista, G. Tesar, Youran Fan, 2015, Epilepsy & Behavior.